The EACR Advisory Council provides advice and guidance to the EACR Board and plays an important role in ensuring the EACR is successful in its mission to support European cancer researchers.
Mariano Barbacid, AXA-CNIO Professor of Molecular Oncology, Spanish National Cancer Research Center (CNIO)
Michael Baumann, Chairman and Scientific Director, German Cancer Research Center (DKFZ)
Johanna Bendell, Chief Development Officer, Oncology, Pfizer
Anton Berns, Former group leader and Scientific Director, Netherlands Cancer Institute (NKI)
Susan Galbraith, Executive Vice President, Oncology Research & Development, AstraZeneca
Susan Gasser, Director, ISREC Foundation
Douglas Hanahan, Ludwig Institute for Cancer Research and Agora Translational Cancer Research Center, Lausanne
Carl-Henrik Heldin, Uppsala University
Fumihiko Ishikawa, Professor of Pathology and Program Director at Visionary Initiatives, Institute of Science Tokyo and Team Director and Advisor to President, RIKEN
Elaine Mardis, Co-Executive Director, The Institute for Genomic Medicine at Nationwide Children’s Hospital and Professor of Pediatrics, The Ohio State University College of Medicine
Alberto Mantovani, Scientific Director, Istituto Clinico Humanitas, Emeritus Professor, Humanitas University, Milan
Moshe Oren, Professor emeritus, Weizmann Institute of Science (Chair)
Marta Puyol, Scientific Director, Spanish Association against Cancer Scientific Foundation (FC AECC)
Charlie Swanton, CRUK Chief Clinician
Karen Vousden, Principal Group Leader, The Francis Crick Institute
Otmar Wiestler, Past President of the Helmholtz Association